Cann American Corp
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $0.0009
- Today's High:
- $0.0009
- Open Price:
- $0.0009
- 52W Low:
- $0.001
- 52W High:
- $0.0178
- Prev. Close:
- $0.0009
- Volume:
- 0
Company Statistics
- Market Cap.:
- $421
- Book Value:
- 0.001
- Revenue TTM:
- $13230
- Operating Margin TTM:
- -2126.42%
- Gross Profit TTM:
- $16710
- Profit Margin:
- 0%
- Return on Assets TTM:
- -84.62%
- Return on Equity TTM:
- -259.65%
Company Profile
Cann American Corp had its IPO on under the ticker symbol CNNA.
The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. Cann American Corp has a staff strength of 1 employees.
Stock update
Shares of Cann American Corp opened at $0 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $0 - $0, and closed at $0.
This is a 0% increase from the previous day's closing price.
A total volume of 0 shares were traded at the close of the day’s session.
In the last one week, shares of Cann American Corp have slipped by -18.18%.
Cann American Corp's Key Ratios
Cann American Corp has a market cap of $421, indicating a price to book ratio of 0.0007 and a price to sales ratio of 0.0306.
In the last 12-months Cann American Corp’s revenue was $13230 with a gross profit of $16710 and an EBITDA of $-275984. The EBITDA ratio measures Cann American Corp's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Cann American Corp’s operating margin was -2126.42% while its return on assets stood at -84.62% with a return of equity of -259.65%.
In Q2.6666666666667, Cann American Corp’s quarterly earnings growth was a positive 0% while revenue growth was a negative 50.7%.
Cann American Corp’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
Its diluted EPS in the last 12-months stands at $-41.29 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Cann American Corp’s profitability.
Cann American Corp stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of -0.0002. Its price to sales ratio in the trailing 12-months stood at 0.0306.
Cann American Corp stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $0
- Total Liabilities
- $8655.00
- Operating Cash Flow
- $0
- Capital Expenditure
- $0
- Dividend Payout Ratio
- 0%
Cann American Corp ended 2024 with $0 in total assets and $0 in total liabilities. Its intangible assets were valued at $0 while shareholder equity stood at $0.
Cann American Corp ended 2024 with $0 in deferred long-term liabilities, $8655.00 in other current liabilities, 927419.00 in common stock, $-5387366.00 in retained earnings and $0 in goodwill. Its cash balance stood at $0 and cash and short-term investments were $0. The company’s total short-term debt was $0 while long-term debt stood at $0.
Cann American Corp’s total current assets stands at $174497.00 while long-term investments were $0 and short-term investments were $0. Its net receivables were $0 compared to accounts payable of $8655.00 and inventory worth $0.
In 2024, Cann American Corp's operating cash flow was $0 while its capital expenditure stood at $0.
Comparatively, Cann American Corp paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $0
- 52-Week High
- $0.0178
- 52-Week Low
- $0.001
- Analyst Target Price
- $
Cann American Corp stock is currently trading at $0 per share. It touched a 52-week high of $0.0178 and a 52-week low of $0.0178. Analysts tracking the stock have a 12-month average target price of $.
Its 50-day moving average was $0 and 200-day moving average was $0 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 953% of the company’s stock are held by insiders while 0% are held by institutions.
Frequently Asked Questions About Cann American Corp
Similar Industry Stocks (Drug Manufacturers-Specialty & Generic)
Most Active
Top Gainers
Top Losers
About
Cann American Corp., a development stage company, focuses on the development of Cannabis sativa strains for pets in various European Union countries. The company was formerly known as Canamed4Pets, Inc. and changed its name to Cann American Corp. in December 2019. Cann American Corp. was founded in 2004 and is based in Cloverdale, California.